Agyany Pharma LTD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3) (NCT07285369) | Agyany Pharma LTD | 2025-03-01 |
| High-Dose Ambroxol in GBA1-Related Parkinson (NCT06193421) | Agyany Pharma LTD | 2023-10-24 |
Track Agyany Pharma LTD automatically
Every clearance here is in the API, with alerts when new ones post.